Anti-Cytoskeletal Autoantibodies: Diagnostic Significance For Liver Diseases, Infections And Systemic Autoimmune Diseases

References

• Johnson G D, Holborow E J, Glynn L F. Antibody to smooth muscle in patients with liver disease. Lancet 1965; ii: 878–879
   Google Scholar
• Toh B H. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979; 38: 621–628
   PubMed Web of Science ®Google Scholar
• Kurki P, Virtanen I. The detection of human antibodies against cytoskeletal components. J Immunol Meths 1984; 57: 208–223
   Google Scholar
• Oliver J M, Senecal J L, Rothfield N L. Autoantibodies to the cytoskeleton in human sera. Cell Muscle Motil 1985; 6: 55–74
   Google Scholar
• Farrow L J, Holborow E J, Brighton W P. Reaction of human smooth muscle antibody with liver cells. Nature New Biol 1971; 232: 186–187
   Google Scholar
• Whittingham S, Mackay I R, Irwin J. Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet 1966; i: 1333–1335
   Google Scholar
• Gabbiani G, Ryan G B, Lamelin J P, Vassalli P, Majno G, Bouvier C A, Cruchard A, Luscher E F. Human smooth muscle autoantibody. Its identification as anti‐actin antibody and a study of its binding to non‐muscle cells. Am J Pathol 1973; 72: 473–478
   PubMed Web of Science ®Google Scholar
• Toh B H, Gallichio H A, Jeffrey P L, Livett B G, Muller H K, Cauchi M N, Clarke F M. Anti‐actin stains synapses. Nature 1976; 264: 648–650
   PubMedGoogle Scholar
• Bottazzo G F, Florin‐Christesen A, Fairfax A, Swana G, Doniach D, Groschel‐Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Path 1976; 29: 403–410
   PubMed Web of Science ®Google Scholar
• Fusconi M, Cassani F, Zauli M L, Ballardini G, Volta U, Bian‐chi F B. Anti‐actin antibodies: a new test for an old problem. J Immunol Meths 1990; 130: 1–8
   PubMed Web of Science ®Google Scholar
• Harmer J H, Lolait S J, Toh B H, Pedersen J S, Chaponnier C, Gabbiani G. Actin depolymerising factor and the organisation and distribution of actin in astrocytomas and meningiomas. Br J Cancer 1983; 48: 89–93
   PubMedGoogle Scholar
• Bretherton L, Brown C, Pedersen J S, Toh B H, Clarke F M, Mackay I R, Gust I D. ELISTA assay for IgG autoantibody to G‐actin: Comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol 1983; 51: 611–616
   PubMedGoogle Scholar
• Pedersen J S, Toh B H, Mackay I R, Tait B D, Gust I D, Kastelan A, Hadzic N. Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol 1982; 48: 527–532
   PubMed Web of Science ®Google Scholar
• Kurki P, Miettinen A, Salaspuro M, Virtanen I, Stenman S. Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Hepatology 1983; 3: 297–302
   PubMedGoogle Scholar
• Cunningham A L, Mackay I R, Frazer I H, Brown C, Pedersen J S, Toh B H, Tait B D, Clarke F M. Antibody to G‐actin in different categories of alcoholic liver disease: quantification by an ELISA and significance for alcoholic cirrhosis. Clin Immunol Immunopathol 1985; 34: 158–164
   PubMedGoogle Scholar
• Hartman K R, Mallet M K, Nath J, Wright D G. Antibodies to actin in autoimmune neutropenia. Blood 1990; 75: 746–743
   Google Scholar
• Williams C L, Lennon V A. Thymic B lymphocyte clones from patients with myaesthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, α actinin and actin. J Exp Med 1986; 164: 1043–1059
   PubMed Web of Science ®Google Scholar
• Cunningham M W, McCormack J M, Talaber L R, Harley J B, Ayoub E M, Muneer R S, Chun L T, Reddy D V. Human monoclonal antibodies reactive with antigens of the group A streptococcus and human heart. J Immunol 1988; 141: 2760–2766
   PubMed Web of Science ®Google Scholar
• Senecal J L, Fortin S, Roussin A, Joyal F. Anticytoskeletal autoantibody to microfilament anchorage sites recognizes novel focal contact proteins. J Clin Invest 1987; 80: 778–785
   Google Scholar
• Georgatos S D, Blobel G. Lamin B constitutes an intermediate filament attachment site at the nuclear envelope. J Cell Biol 1987; 105: 117–125
   PubMedGoogle Scholar
• Zauli D, Crespi C, Bianchi F B, Pisi E. Immunofluorescent detection of anti‐cytoskeleton antibodies using vinblastine‐treated mononuclear cells. J Immunol Meths 1985; 82: 77–82
   Google Scholar
• Kurki P, Virtanen I, Stenman S, Linder E. Human smooth muscle antibodies reacting with intermediate filaments. Nature 1977; 268: 240–241
   PubMedGoogle Scholar
• Toh B H, Yildiz A, Solelo J, Osung O, Holborow E J, Kanakoudi F, Small J V. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol 1979; 37: 76–82
   PubMedGoogle Scholar
• Pedersen J S, Toh B H, Locarnini S A, Gust I D, Shyamala G NS. Autoantibody to intermediate filaments in viral hepatitis. Clin Immunol Immunopathol 1981; 21: 154–161
   Google Scholar
• Mackay I R, Frazer I H, Toh B H, Pedersen J S, Alter H J. Absence of autoimmune serological reactions in chronic nonA, nonB viral hepatitis. Clin Exp Immunol 1985; 61: 39–43
   Google Scholar
• Brown C B, Pedersen J S, Underwood J R, Toh B H. Autoantibodies to intermediate filaments in acute viral hepatitis A., B., and nonA nonB are directed against vimentin. J Clin Lab Immunol 1986; 19: 1–4
   PubMedGoogle Scholar
• Alcover A, Carmen H, Avila J. Human vimentin autoantibodies preferentially interact with a peptide of 30 kDa mol wt, located close to the amino‐terminal of the molecule. Clin Exp Immunol 1985; 61: 24–30
   Google Scholar
• Linder E P, Kurki P, Andersson L C. Autoantibody to intermediate filaments in infectious mononucleosis. Clin Immunol lmmunopathol 1979; 14: 411–441
   PubMedGoogle Scholar
• Bretherton L, Toh B H. IgM autoantibody to intermediate filaments in infectious mononucleosis. J Clin Lab Immunol 1981; 5: 7–10
   PubMedGoogle Scholar
• Mortazavi‐Milani S M, Badakere S S, Holborow E L. Antibody to intermediate filaments of cytoskeleton in sera of patients with acute malaria. Clin Exp Immunol 1984; 55: 177–182
   Google Scholar
• Boehme M WJ, Kataaha P K, Holborow E J. Autoantibodies to intermediate filaments in sera of patients with Schistosoma mansoni infection. Clin Exp Immunol 1989; 77: 230–233
   Google Scholar
• Bretherton L, Toh B H, Jack I. IgM autoantibody to intermediate filaments in Mycoplasma pneumoniae infections. Clin Immunol Immunopathol 1981; 18: 425–430
   PubMedGoogle Scholar
• Kurki P, Helve T, Virtanen I. Antibodies to cytoplasmic intermediate filaments in rheumatic diseases. J Rheumatol 1983; 10: 558–562
   Google Scholar
• Alcover A, Molano J, Renart J, Gil‐Aguado A, Nieto A, Avila J. Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus. Arth Rheum 1984; 27: 922–928
   PubMedGoogle Scholar
• Blaschek M A, Boehme M, Jouquan J, Simitzis A ‐M, Fifas S, Le Goff P, Youinou P. Relation of antivimentin antibodies to anticardiolipin antibodies in systemic lupus erythematosus. Ann Rheum Dis 1988; 47: 708–716
   PubMedGoogle Scholar
• Senecal J L, Rauch J. Hybridoma lupus autoantibodies can bind major cytoskeletal filaments in the absence of DNA‐binding activity. Arth Rheum 1988; 31: 864–875
   PubMed Web of Science ®Google Scholar
• Sanchez A, Ossorio C, Alvaro‐Gracia J M, Padilla R, Avila J. A subset of antibodies from the sera of patients with systemic lupus erythematosus react with vimentin and DNA. J Rheum 1990; 17: 205–209
   Google Scholar
• Osung O, Chaudra M, Holborow E J. Antibodies to intermediate filaments of the cytoskeleton in rheumatoid arthritis. Ann Rheum Dis 1982; 41: 69–73
   Google Scholar
• Kataaha P K, Mortazavi‐Milani S M, Russell G, Holborow E J. Anti‐intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis. Ann Rheum Dis 1985; 44: 446–449
   PubMed Web of Science ®Google Scholar
• Tsuneda Y, Kitajima K, Mori S. Autoantibodies to vimentin‐type intermediate filament in patients with progressive systemic sclerosis. J Dermatol 1988; 15: 128–132
   Google Scholar
• Senecal J L, Oliver J, Rothfield N. Anticytoskeletal antibodies (A.‐CY) and connective tissue diseases (CTD). Clin Res 1983; 31: 531A
   Google Scholar
• Dasgupta B, Duke O, Kyle V, Macfarlane D G, Hazleman B L, Panayi G S. Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis 1987; 46: 746–749
   Google Scholar
• Landay A, Kubagawa H, Cooper M D. Idiotype analysis of a B cell clone with anti‐intermediate filament specificity in a patient with Sjogren's syndrome: involvement of five subpopu‐lations producing different imnmunoglobulin isotypes. J Immunol 1986; 137: 129–136
   Google Scholar
• Zauli D, Crespi C, Dall'Amore P, Bianchi F B, Pisi E. Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease. Digestion 1985; 32: 140–144
   PubMed Web of Science ®Google Scholar
• Akoglu T, Kozakoglu H, Akoglu E. Antibody to intermediate filaments of the cytoskeleton in patients with Behcet's disease. Clin Immunol Immunopathol 1986; 41: 427–432
   Google Scholar
• Tazzari P L, Gobbi M, Zauli D, Tassinari A, Crespi C, Miserocchi F, Dinoto A, Bandini G, Ricci P, Tura S. Close association between antibodies to cytoskeletal intermediate filaments, and chronic graft‐versus‐host disease. Transplantation 1987; 44: 234–236
   Google Scholar
• Johnson G D, Carvalho A, Holborow E J, Goddard D H, Russell G. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Ann Rheum Dis 1981; 40: 263–266
   PubMedGoogle Scholar
• Scott D L, Delamere J P, Jones I J, Walton K W. Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis. Ann Rheum Dis 1981; 40: 267–271
   PubMedGoogle Scholar
• Quismorio F P, Kaufman R L, Beardmore T, Mongan E S. Reactivity of serum antibodies to the keratin layer of rat oesophagus in patients with rheumatoid arthritis. Arth Rheum 1983; 26: 494–499
   PubMed Web of Science ®Google Scholar
• Hintner H, Steinert P M, Lawley T L. Human upper epidermal cytoplasmic antibodies are directed against keratin intermediate filament proteins. J Clin Invest 1983; 71: 1344–1351
   Google Scholar
• Viae J, Paire J, Desgranges C, Iwatsuki K, Thivolet J. Epstein‐Barr virus‐transformed lymphocytes from patients with bullous diseases produce autoantibodies to cytokeratins. Clin Immunol lmmunopathol 1986; 39: 277–284
   Google Scholar
• Aoki S, Yaoita H, Kitajima Y. An elevated level of autoantibodies against 48‐ to 50‐kda keratins in the serum of patients with psoriasis. J Invest Dermatol 1989; 92: 179–183
   PubMed Web of Science ®Google Scholar
• Sotelo J, Gibbs C J, Gajdusek C. Autoantibodies against axonal neurofilaments in patients with kuru and Creutzfeldt‐Jacob disease. Science 1980; 210: 190–193
   Google Scholar
• Mitrova E, Mayer V. Antibodies to axonal neurifilaments in Creutzfeldt‐Jacob disease and other dementias. Acta Virol 1989; 33: 371–374
   Google Scholar
• Toh B H, Gibbs C J, Jr, Gajdusek C, Goudsmit J, Dahl D. The 200‐ and the 150‐kDa neurofilament proteins react with IgG autoantibodies from patients with kuru, Creutzfeldt‐Jacob disease and other dementias. Proc Natl Acad Set USA 1985; 82: 3485–3489
   Google Scholar
• Braxton D B, Williams M, Kamali D, Chin S, Liem R, Latov N. Specificity of human anti‐neurofilament autoantibodies. J Neu‐roimmunol 1989; 21: 193–203
   PubMed Web of Science ®Google Scholar
• Robbins M L, Kornguth S E, Bell C L, Kalinke T, England D, Turski P, Graziano F M. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging. Arth Rheum 1988; 18: 1179–1184
   Google Scholar
• Kornguth S E, Kalinke T, Grunwald G B, Schutta H, Dahl D. Anti‐neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res 1986; 46: 2588–2595
   PubMed Web of Science ®Google Scholar
• Kingsley B S, Gaskin F, Fu S M. Human antibodies to neurofibrillary tangles and astrocytes in Alzheimer's disease. J Neuro‐immunol 1988; 19: 89–99
   PubMedGoogle Scholar
• Underwood J R, Pedersen J S, Chalmers P J, Toh B H. Hybrids from normal, germ free, nude, and neonatal mice produce monoclonal autoantibodies to eight different intracellular structures. Clin Exp Immunol 1985; 60: 417–426
   PubMedGoogle Scholar
• Freitas A A, Guilbert B, Holmberg D, Wennerstrom G, Coutinho A, Avrameas S. Analysis of autoantibody reactivities in hybridoma collections derived from normal adult BALB/c mice. Ann Inst Pasteur Immunol 1986; 137D: 33–45
   PubMedGoogle Scholar
• Seigneurin J M, Guibert B, Bourgeat M J, Avrameas S. Poly‐specific natural antibodies and autoantibodies secreted by human lymphocytes immortalized with Epstein‐Barr virus. Blood 1988; 71: 581–585
   PubMed Web of Science ®Google Scholar
• Lydyard P M, Quartey‐Papafio R, Broker B, Mackenzie L, Jopuquan J, Blaschek M A, Steele J, Petrou M, Collins P, Isen‐berg D, Youinou P Y. The antibody repertoire in early human B cells. 1. High frequency of autoreactivity and polyspecificity. Scan J Immunol 1990; 31: 33–43
   PubMed Web of Science ®Google Scholar
• Goni F R, Chen P P, McGinnis D, Arjonilla M L, Fernandez J, Carson D, Solomon A, Mendez E, Frangione B. Structural and idiotypic characterisation of the L chains of human IgM autoantibodies with different specificities. J Immunol 1989; 142: 3158–3163
   PubMedGoogle Scholar
• Gosni F R, Frangione B. Association between human IgM autoantibodies and kappa chain. J Immunogenet 1987; 14: 15–22
   Google Scholar
• Ternynick T, Bleux C, Gregoire J, Avrameas S, Kanellopoulos‐Langevin C. Comparison between autoantibodies arising during Trypanosoma cruzi infection in mice and natural autoantibodies. J Immunol 1990; 144: 1504–1511
   Google Scholar
• Fujinami R S, Oldstone M BA, Wroblewska Z, Frankel M E, Koprowski H. Molecular mimicry in virus infection: cross reaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 1983; 80: 2346–2350
   PubMed Web of Science ®Google Scholar
• Sairenji T, Nguyen Q V, Woda B, Humphreys R E. Immune response to intermediate filament‐associated, Epstein‐Barr virus‐induced early antigen. J Immunol 1987; 138: 2645–2652
   PubMed Web of Science ®Google Scholar
• Grabar P. Autoantibodies and the physiological role of immunoglobulins. Immunol Tod 1983; 4: 337–340
   PubMedGoogle Scholar
• Mahana W, Guilbert B, Avrameas S. Regulation of the human immune response by polyspecific natural autoantibodies. Ann Inst Pasteur Immunol 1988; 139: 349–360
   Google Scholar